BioSpace News Archive

Pharm Country

OTC Markets Group Welcomes Lombard Medical to OTCQX

Lombard Medical begins trading today on OTCQX under the symbol “EVARF.”

November 9, 2017
·
1 min read
Pharm Country

AmerisourceBergen Increases Dividend 4 Percent

The Board of Directors of AmerisourceBergen Corporation today increased the Company’s quarterly dividend rate 4 percent to $0.38 per common share from $0.365 per common share.

November 9, 2017
·
5 min read
BioForest

Super-resolution Photoacoustic Imaging Could Allow Scientists to Watch Blood Vessels With Improved Resolution, Published in the Optical Society

Researchers have reported an approach to photoacoustic imaging that offers vastly improved resolution, setting the stage for detailed in vivo imaging of deep tissue.

November 9, 2017
·
6 min read
FDA

Aspect Imaging Snags CE Mark for Embrace Neonatal MRI System in the NICU

Embrace Neonatal MRI can now be used and sold in EU countries and in non-EU countries that rely on CE certification.

November 9, 2017
·
3 min read
Business

Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights

$16.3 million cash and cash equivalents as of September 30, 2017 as compared to $27.3 million as of June 30, 2017.

November 9, 2017
·
11 min read
Business

PharMerica Reports Third Quarter 2017 Results

Revenues for the third quarter of 2017 were $595.1 million compared with $512.6 million for the third quarter of 2016.

November 9, 2017
·
17 min read
Business

Wilson Therapeutics’ Nomination Committee Appointed

The Nomination Committee has appointed Sarah Shackelton as its chairman.

November 9, 2017
·
1 min read
Business

Repligen Reports Third Quarter 2017 Financial Results

Revenue for the third quarter of 2017 increased to $36.6 million compared to $24.7 million for the third quarter of 2016, a year-over-year gain of 48% as recorded, or 47% at constant currency.

November 9, 2017
·
20 min read
Business

Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies

The company also increased number of clinical trials and studies it supports to 191, up 59%.

November 9, 2017
·
14 min read
Business

Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook

Q3’17 Product revenue from continuing operations increased 14% year-over-year, led by Biologics growth of 70% year-over-year.

November 9, 2017
·
19 min read